what's new in the world of dental products - kovanaze
KOVANAZE - Needle free nasal spray anesthetic... potential practice builder??
Kovanaze st-renatus.com/ has the potential to revolutionize anesthesia delivery in dentistry. What are the most important things dentists should know about nasally-administered Kovanaze? Kovanaze provides regional, pulpal anesthesia with 96% efficacy in teeth Nos. 5–12, therefore Kovanaze offers a needle-free alternative to the majority of anterior maxillary injections.
Additionally, patients may not experience the same sensations of numbness or tingling of the lips and cheeks associated with injectable dental anesthetics.
Kovanaze is the first no-needle regional, pulpal anesthetic administered via nasal spray to be approved by the US Food and Drug Administration (FDA), and it offers patients a safe and effective, needle-free alternative to anesthetize teeth 4-13 for restorative dental procedures.
(To continue reading article from Dentistry IQ click on image below)
Kovanaze st-renatus.com/ has the potential to revolutionize anesthesia delivery in dentistry. What are the most important things dentists should know about nasally-administered Kovanaze? Kovanaze provides regional, pulpal anesthesia with 96% efficacy in teeth Nos. 5–12, therefore Kovanaze offers a needle-free alternative to the majority of anterior maxillary injections.
Additionally, patients may not experience the same sensations of numbness or tingling of the lips and cheeks associated with injectable dental anesthetics.
Kovanaze is the first no-needle regional, pulpal anesthetic administered via nasal spray to be approved by the US Food and Drug Administration (FDA), and it offers patients a safe and effective, needle-free alternative to anesthetize teeth 4-13 for restorative dental procedures.
(To continue reading article from Dentistry IQ click on image below)
Nasal Spray Utilizing Needle-Free Technology
- INDICATION: KOVANAZE is indicated for regional anesthesia when performing a restorative procedure on Teeth 4-13 and A-J in adults and children who weigh 40 kg or more.
- Patients may not experience the same sensations of numbness or tingling of the lips and cheeks associated with injectable anesthetics.
- Kovanaze provides regional anesthesia with 96% efficacy in teeth #5-12, 64% in #4 and #13*, therefore Kovanaze offers a needle-free alternative to the majority of anterior maxillary injections.
Read more about kovanaze from spear education
Download and print the full article from Spear Education below